Education
About Us
Working with TipRanks
Follow Us
OmniAb (OABI)
NASDAQ:OABI
Earnings Data
Report Date
Aug 07, 2025TBA Not Confirmed
Period Ending
2025 (Q2)Consensus EPS Forecast
-0.15Last Year’s EPS
-0.13Same Quarter Last Year
Strong Buy
Based on 8 Analysts Ratings
---
Earnings Call Summary
Earnings Call Date:May 08, 2025
|% Change Since: 0.64%
|Next Earnings Date:Aug 07, 2025
Earnings Call Sentiment|Positive
The earnings call reflects a positive outlook for OmniAb with strong growth in deals and programs, a successful launch of a new product line, and increased revenue. However, challenges such as net losses and lower royalty revenues persist. Overall, the positives in terms of strategic growth and financial performance outweigh the negatives.Company Guidance
During OmniAb, Inc.'s first-quarter 2025 financial results call, the company provided optimistic guidance fueled by strong deal flow, adding new partners, and achieving a notable 95 active partners by the end of the quarter. OmniAb's pipeline grew to 378 active programs, despite natural attrition in drug development, with 33 active clinical programs and approved products reported. The launch of the exploration partner access program was a significant milestone, offering partners the ability to integrate the exploration instrument into their workflows, potentially generating new revenue streams. Financially, the company reported a 10.5% increase in revenue to $4.2 million, attributed to higher milestone revenue, though the net loss for the quarter was $18.2 million. OmniAb maintained its 2025 revenue guidance of $20-25 million, excluding contributions from the exploration program, and revised its operating expense guidance to $85-90 million, down from $90-95 million.Strong Start to 2025
2025 is off to a very good start with strong deal flow, both platform and asset-based, and a growing pipeline of partnered programs.
Launch of Exploration Partner Access Program
OmniAb launched the exploration partner access program, allowing partners to purchase exploration instruments for use in their labs, creating new revenue streams.
Increase in Active Partners and Programs
Exited Q1 with 95 active partners and 378 active programs, showing continued growth in partner and program metrics.
Revenue Increase
Q1 2025 revenue increased to $4.2 million from $3.8 million in Q1 2024, mainly due to higher milestone revenue.
Reduction in Operating Expenses
Operating expenses declined to $23 million from $26.4 million in the prior year period, with cost savings in R&D and G&A.
Upcoming Presentations and Conferences
OmniAb will be showcasing exploration at the PEGs conference in Boston and ASCO annual meeting in Chicago.
---
OABI Earnings History
The table shows recent earnings report dates and whether the forecast was beat or missed. See the change in forecast and EPS from the previous year.
Beat
Missed
---
OABI Earnings-Related Price Changes
Report Date | Price 1 Day Before | Price 1 Day After | Percentage Change |
|---|---|---|---|
May 08, 2025 | $1.57 | $1.44 | -8.28% |
Mar 18, 2025 | $3.19 | $2.54 | -20.38% |
Nov 12, 2024 | $4.49 | $4.07 | -9.35% |
Aug 08, 2024 | $4.29 | $4.24 | -1.17% |
Earnings announcements can affect a stock’s price. This table shows the stock's price the day before and the day after recent earnings reports, including the percentage change.
---
FAQ
When does OmniAb (OABI) report earnings?
OmniAb (OABI) is schdueled to report earning on Aug 07, 2025, TBA Not Confirmed.
What is OmniAb (OABI) earnings time?
OmniAb (OABI) earnings time is at Aug 07, 2025, TBA Not Confirmed.
Where can I see when companies are reporting earnings?
You can see which companies are reporting today on our designated earnings calendar.
What companies are reporting earnings today?
You can see a list of the companies which are reporting today on TipRanks earnings calendar.
What is OABI EPS forecast?
OABI EPS forecast for the fiscal quarter 2025 (Q2) is -0.15.
---